This HTML5 document contains 150 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
n12http://dx.doi.org/10.1086/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n9http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q44138863
rdf:type
wikibase:Item
schema:description
1998年學術文章 articol științific научна статия наукова стаття, опублікована в червні 1998 1998年學術文章 научни чланак artykuł naukowy 1998年学术文章 artikull shkencor article científic naučni članak জুন ১৯৯৮-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ 1998年学术文章 vitenskapelig artikkel artigo científico מאמר מדעי 1998 nî lūn-bûn επιστημονικό άρθρο scientific article published in June 1998 article scientifique scienca artikolo 1998年の論文 vědecký článek bài báo khoa học 1998年学术文章 1998年學術文章 articolo scientifico 1998年学术文章 мақолаи илмӣ bilimsel makale 1998年学术文章 wissenschaftlicher Artikel vitskapeleg artikkel artigo científico wetenschappelijk artikel գիտական հոդված հրատարակված 1998 թվականի հունիսին teaduslik artikkel 1998년 논문 1998年學術文章 tudományos cikk научная статья tieteellinen artikkeli artículo científico publicado en 1998 vetenskaplig artikel artikulong pang-agham artículu científicu espublizáu en 1998 vedecký článok บทความทางวิทยาศาสตร์ 1998年學術文章 1998年学术文章 artigo científico სამეცნიერო სტატია مقالة علمية نشرت في يونيو 1998 scientific article published in June 1998 artikel ilmiah videnskabelig artikel article scientific scientific article published in June 1998 научни чланак
p:P577
wds:Q44138863-4A53DE71-783A-4B35-BBCF-C93E1449762A
wdt:P577
1998-06-01T00:00:00Z
p:P407
wds:Q44138863-F2C12313-52CC-45EA-8D18-EF28190E48A1
wdt:P407
wd:Q1860
p:P2093
wds:Q44138863-2C9E2DBC-D57B-4DF5-8A6C-83790D628799 wds:Q44138863-2F4A1C5C-71ED-4688-9BBC-9EFE265FF5B8 wds:Q44138863-1DBAFD4A-9C61-474E-AD2E-BC1B7D2CFFF3 wds:Q44138863-7CB9359C-97F4-4115-8F61-653DB403793E wds:Q44138863-6FD31970-8227-49E6-AFA8-A62C52691957 wds:Q44138863-72AD5CDF-7CF0-4FCF-830D-1D48056EB62F wds:Q44138863-881D1B5D-F058-449D-993B-5B7B513A19DE wds:Q44138863-89565B8F-A3C8-40AE-BB00-9F93CC65BC35 wds:Q44138863-83AF4CE9-589A-49E4-8B0C-9275E2D66EEC wds:Q44138863-4614B326-F282-4B8B-A885-EDFD738E45CD wds:Q44138863-30F1C65C-F183-4F68-BF8E-7F8C44FD3510 wds:Q44138863-3301C80C-FB04-4A0B-AF26-A889A54A78D9 wds:Q44138863-623C38F9-0CA8-4E74-A76C-2FEED2E5C61B wds:Q44138863-6D1A4C03-A545-49E3-925F-7BDE35A0961A wds:Q44138863-61B93CDC-E600-422E-9249-BFBA6E455521 wds:Q44138863-E4C3FDB8-39A4-4904-8079-9B1A01E3E791 wds:Q44138863-E0D5C8DB-9E9C-4E36-BE0C-CDD0EFCF764B wds:Q44138863-E78C04A7-53BE-44FB-8924-4C03ED282A1F wds:Q44138863-E5735EE1-35D6-4677-89C8-9D789A641790 wds:Q44138863-BFE73121-3206-4E63-8FAA-FF9285FF0454 wds:Q44138863-C5D070E4-5A12-44E4-B109-07BA25B3FAB4 wds:Q44138863-C6691946-50B0-457D-B41F-4FDE1929A48E
wdt:P2093
B Wizel L Farley A Magill B T Hall P F Sun J A Stoute B T Wellde U Krzych K Kester J A Tine R A Wirtz J C Sadoff S Kumar D C Kaslow A V Hill C de Taisne L W Church K P Guito J M Crutcher S Hoffman R Anders D E Lanar
rdfs:label
Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.
skos:prefLabel
Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.
schema:name
Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria. Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria.
p:P50
wds:Q44138863-A8B04740-7644-42C6-B649-F68BA41F9B8B wds:Q44138863-E7994C3B-ECF3-4A80-BDFE-7154AB5AB32C wds:Q44138863-1FE894B2-8A4B-43EF-918E-B72694679980
wdt:P50
wd:Q60730031 wd:Q89223351 wd:Q106991965
p:P1476
wds:Q44138863-D4332E03-6652-4395-81CE-926B7920AF35
wdt:P1476
Phase I/IIa safety, immunogenicity, and efficacy trial of NYVAC-Pf7, a pox-vectored, multiantigen, multistage vaccine candidate for Plasmodium falciparum malaria
p:P304
wds:Q44138863-16C8C281-319B-4E20-8AC6-A61A94107D4E
wdt:P304
1664-1673
p:P31
wds:Q44138863-E762BF66-30FE-4C33-B82C-85CB3A9044BD
wdt:P31
wd:Q13442814
p:P921
wds:Q44138863-BA3CDC31-5536-4EBC-9F2A-70693186040F wds:Q44138863-CCD6A696-03AB-4565-A175-9561107061B9 wds:Q44138863-346E17F4-C3AB-470A-B0F3-F8489BCA52CA wds:Q44138863-EAD367AC-6AFD-4B10-854A-26B041F8582A
wdt:P921
wd:Q12156 wd:Q6741353 wd:Q311383 wd:Q5452194
p:P698
wds:Q44138863-826A3E91-CDA1-4E0B-9B6C-8343691DF938
wdtn:P698
n9:9607847
wdt:P698
9607847
p:P1433
wds:Q44138863-E40EF421-6DF3-4081-8AF5-F91112432D14
wdt:P1433
wd:Q4051141
p:P433
wds:Q44138863-E32E0257-963F-4E18-B391-D0567457B87A
p:P478
wds:Q44138863-DD5B480B-F02D-4C59-AA89-BA7FA32A4D54
wdt:P433
6
wdt:P478
177
p:P1104
wds:Q44138863-8436EBA3-FC01-45DD-9D38-86CC0D140F92
wdt:P1104
10
p:P356
wds:Q44138863-02B33768-E71F-4F75-8818-349A855D73BA
wdtn:P356
n12:515331
wdt:P356
10.1086/515331
p:P5875
wds:Q44138863-0D824A8A-60D1-4CA5-A7FA-1ECFE0F1A6BE
wdt:P5875
13676133